Affordable Access

Publisher Website

Treatment of Hepatitis C as Prevention: A Modeling Case Study in Vietnam

Public Library of Science
Publication Date
DOI: 10.1371/journal.pone.0034548
  • Research Article
  • Medicine
  • Clinical Research Design
  • Modeling
  • Epidemiology
  • Gastroenterology And Hepatology
  • Liver Diseases
  • Global Health
  • Infectious Diseases
  • Viral Diseases
  • Hepatitis
  • Hepatitis C
  • Infectious Disease Modeling
  • Public Health
  • Behavioral And Social Aspects Of Health
  • Preventive Medicine
  • Socioeconomic Aspects Of Health
  • Mathematics
  • Medicine


Background Treatment of hepatitis C (HCV) is very effective, achieving a cure in 50–90% of patients. Besides its own good for individuals, this most likely translates in reduced transmission, but this phenomenon has yet to be fully explored. Methods and Findings In this mathematical modeling study done in the context of Vietnam, we estimated the public health benefit that HCV therapy for injecting drug users (IDUs) may achieve. Treatment coverage of 25, 50 and 75% of chronically HCV-infected IDUs (4 years into infection) is predicted to reduce the chronic HCV viremia prevalence respectively by 21, 37 and 50%, 11 years after full scale up to the intended coverage. At a constant 50% coverage level, earlier treatment, 3, 2, and 1 year into infection is predicted to reduce the chronic HCV viremia prevalence by 46, 60 and 85%. In these later 3 scenarios, for every 100 treatment courses provided, a total of respectively 50, 61 and 94 new infections could be averted. These benefits were projected in the context of current low coverage of methadone maintenance therapy and needles/syringes exchange programs, and these services expansion showed complementary preventive benefits to HCV therapy. The program treatment commitment associated with the various scenarios is deemed reasonable. Our model projections are robust under adjustment for uncertainty in the model parameter values. Conclusions In this case study in Vietnam, we project that treatment of HCV for injecting drug users will have a preventative herd effect in addition to curing patients in need for therapy, achieving a substantial reduction in HCV transmission and prevalence.

There are no comments yet on this publication. Be the first to share your thoughts.